These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 25374385)

  • 1. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
    Liting P; Guoping L; Zhenyue C
    Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
    Pan L; Lu G; Chen Z
    Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography.
    Song Y; Yang Y; Zhang J; Wang Y; He W; Zhang X; Zhu J; Lu Z
    Lipids Health Dis; 2015 Nov; 14():150. PubMed ID: 26582246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention.
    Tian M; Li R; Shan Z; Wang DW; Jiang J; Cui G
    Lipids Health Dis; 2019 Nov; 18(1):202. PubMed ID: 31744496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride-to-HDL cholesterol ratio. Predictive value for CHD severity and new-onset heart failure.
    Yunke Z; Guoping L; Zhenyue C
    Herz; 2014 Feb; 39(1):105-10. PubMed ID: 23588603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Value of the Apolipoprotein B/Apolipoprotein A1 Ratio in Predicting the Rapid Progression of Non-Culprit Coronary Lesions in Acute Coronary Syndrome in Patients with Diabetes Mellitus after Percutaneous Coronary Intervention.
    Zhou Y; Liu H; Yang H; Zhao X; Jiao Y
    Int Heart J; 2023 Jul; 64(4):562-569. PubMed ID: 37460319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Serum LDL-C and ApoB and SYNTAX Score in Patients With Stable Coronary Artery Disease.
    Lin T; Wang L; Guo J; Liu P; Chen L; Wei M; Li G
    Angiology; 2018 Sep; 69(8):724-729. PubMed ID: 29310455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of LDL-CT, non-HDL/HDL ratio, and ApoB/ApoA1 in assessing CHD risk among patients with type 2 diabetes mellitus.
    Păunică I; Mihai AD; Ștefan S; Pantea-Stoian A; Serafinceanu C
    J Diabetes Complications; 2023 Dec; 37(12):108634. PubMed ID: 37918178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.
    Sierra-Johnson J; Fisher RM; Romero-Corral A; Somers VK; Lopez-Jimenez F; Ohrvik J; Walldius G; Hellenius ML; Hamsten A
    Eur Heart J; 2009 Mar; 30(6):710-7. PubMed ID: 18676970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
    Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
    Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C.
    Pencina MJ; D'Agostino RB; Zdrojewski T; Williams K; Thanassoulis G; Furberg CD; Peterson ED; Vasan RS; Sniderman AD
    Eur J Prev Cardiol; 2015 Oct; 22(10):1321-7. PubMed ID: 25633587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis evaluation of universal acute coronary syndrome: the interplay between SYNTAX score and ApoB/ApoA1.
    Wang X; Wang Z; Li B; Yang P
    BMC Cardiovasc Disord; 2020 Jun; 20(1):293. PubMed ID: 32539722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of preoperative platelet-to-albumin ratio and apolipoprotein B-to-apolipoprotein A1 ratio for osteosarcoma in children and adolescents: a retrospective study of 118 cases.
    Ma C; Li R; Yu R; Guo J; Xu J; Yuan X; Guo J
    BMC Cancer; 2022 Jan; 22(1):113. PubMed ID: 35086516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between HDL-cholesterol and apolipoprotein A1 and the severity of coronary artery disease.
    Garfagnini A; Devoto G; Rosselli P; Boggiano P; Venturini M
    Eur Heart J; 1995 Apr; 16(4):465-70. PubMed ID: 7671890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between serum levels of osteoproteins, inflammatory cytokines and coronary heart disease and disease severity].
    Zhao F; Zhang R; Zhao H; Liu T; Ren M; Song Y; Liu S; Cong H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):588-593. PubMed ID: 31198145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDL/apo B ratio predict coronary heart disease in Type 2 diabetes independent of ASCVD risk score: A case-cohort study.
    Rabizadeh S; Rajab A; Mechanick JI; Moosaie F; Rahimi Y; Nakhjavani M; Esteghamati A
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1477-1485. PubMed ID: 33810957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients.
    Liem AH; van de Woestijne AP; Roeters van Lennep HW; Zwinderman AH; van der Steeg WA; Jukema JW
    Curr Med Res Opin; 2008 Feb; 24(2):359-64. PubMed ID: 18081989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study.
    Ren XY; Shi D; Ding J; Cheng ZY; Li HY; Li JS; Pu HQ; Yang AM; He CL; Zhang JP; Ma YB; Zhang YW; Zheng TZ; Bai YN; Cheng N
    Lipids Health Dis; 2019 Feb; 18(1):47. PubMed ID: 30744645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
    Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
    Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
    Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
    PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.